Dr. Kenneth Ho-Ming Yu, MD, MS
- Medicare services, 2024
- 786
- Medicare patients, 2024
- 167
- Part D claims, 2024
- 1,002
- Publications
- 94
- Clinical trials
- 7
- Practice address
- 1275 York Avenue, New York, NY 10065
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Yu's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Kenneth Ho-Ming Yu is a medical oncologist in New York, New York
Dr. Yu practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.
Dr. Yu's NPI, 1073554440, was assigned on June 9, 2006. Dr. Yu graduated from The Johns Hopkins University School of Medicine in 1999. Dr. Yu's New York license number on file is 257085.
- NPI
- 1073554440NPI Registry (opens in a new tab)
- Medicare PAC ID
- 7517996051
- NPI enumeration date
- June 9, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 53
- Medical school graduation
- 1999
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Kenneth Ho-Ming Yu practices at Memorial Sloan Kettering Cancer Center in New York, New York
Dr. Yu's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.
- Memorial Sloan Kettering Cancer Center1275 York Avenue, New York, NY 10065
Source: Dmand AI Affiliation Data
Dr. Kenneth Ho-Ming Yu is affiliated with 4 sites of care and 3 medical groups
Dr. Yu's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Yu to 3 more group practices and clinics and 2 medical groups, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Kenneth Ho-Ming Yu's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yu practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Memorial Sloan Kettering Cancer Center | Available with a free account |
| +3 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Memorial Sloan Kettering Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Kenneth Ho-Ming Yu is one of 458 medical oncologists in New York
Medical oncology is Dr. Yu's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Yu is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Yu's licenses on file in 3 states: New York, New Jersey and Pennsylvania.
Specialties and state licenses
- Medical oncology, New YorkPrimary
- New Jersey license
- Internal medicine, Pennsylvania
Medical oncologists near Dr. Yu
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Kenneth Ho-Ming Yu billed Medicare for 786 services in 2024
CMS data shows 786 Medicare services from Dr. Yu across 4 procedure codes in 2024, for 167 Medicare patients. Medicare paid $73,868 for them.
Dr. Yu's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 7722024: 7862%
Where Dr. Yu's Medicare services took place, 2024
- In an office69488%
- In a facility9212%
Dr. Yu compared with the New York median for medical oncologists, 2024
- Dr. Yu
- New York median
- Medicare services
- 786vs 3402.3 times
- Medicare patients
- 167vs 11249% above
- Part D claims
- 748vs 1305.8 times
Medians across 421 medical oncologists in New York with Dmand AI profiles that report each measure.
Dr. Yu's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Yu?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Yu and other medical oncologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Kenneth Ho-Ming Yu treated 167 Medicare patients in 2024, average age 75
CMS counts 167 Medicare patients who saw Dr. Yu in 2024. The largest group is 65 to 74, with 75 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Yu's median patient age at 74, with 52% women.
Dr. Yu's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Yu's Medicare patients by sex, 2024
- Women7847%
- Men8953%
Chronic conditions among Dr. Yu's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis51%
- Diabetes45%
- Ischemic heart disease44%
- Anxiety37%
- Cancer37%
- Mood disorders29%
Share of Medicare patients with each condition. A patient can have several.
Dr. Yu's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 74
Patient panel by sex, all payers
- Women52%
- Men48%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Kenneth Ho-Ming Yu wrote 1,002 Medicare Part D claims in 2024
In 2024, Dr. Yu wrote 1,002 Medicare Part D claims for 125 patients. 72% of them were for generic drugs. CMS names the drug for 748 of them, across 26 drugs with 11 or more claims each, at $495,118 in total drug cost. In 2023, CMS named 540 claims across 21 drugs.
Dr. Yu's Part D claims by kind of drug, 2024
- Generic724 claims72%
- Brand-name and other278 claims28%
Dr. Yu's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Yu's Part D claims, 2024
- Opioids12%118 of 1,002 claims
- Antibiotics3%32 of 1,002 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 5402024: 74839%
Drugs named by CMS: 26 in 2024, 21 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Kenneth Ho-Ming Yu scored 80 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Yu for performance year 2024, reported as part of a group. Dr. Yu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yu as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Yu's MIPS scores, performance year 2024
- 80of 100Final score
- 70.5of 100Quality
- 40of 100Improvement Activities
- 69of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Kenneth Ho-Ming Yu has 94 publications on record
Dmand AI links 94 papers to Dr. Yu, published from 2011 to 2025. 2018 was the busiest year, with 12. The most frequent topics are Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal and Adenocarcinoma. Dr. Yu has published most often in Cancer. Dr. Yu's most frequent co-authors are David P. Kelsen, MD, Eileen M. O'Reilly, MD and Anna M. Varghese, MD.
Dr. Yu's papers by year, 2016 to 2025
Topics Dr. Yu writes about most
- Pancreatic Neoplasms
- Carcinoma, Pancreatic Ductal
- Adenocarcinoma
- Antineoplastic Combined Chemotherapy Protocols
- Germ-Line Mutation
- Deoxycytidine
- Gemcitabine
- Antineoplastic Agents
Dr. Yu's most frequent co-authors
- David P. Kelsen, MD27 shared papers
- Eileen M. O'Reilly, MD27 shared papers
- Anna M. Varghese, MD24 shared papers
Recent publications by Dr. Yu
See who Dr. Yu researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Yu works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Kenneth Ho-Ming Yu has worked on 7 clinical trials
Dmand AI links Dr. Yu to 7 clinical trials. 5 are still active or recruiting. Conditions studied include Pancreatic Neoplasms, Pancreatic Diseases and Carcinoma, Adenoid Cystic. Memorial Sloan Kettering Cancer Center sponsors the most, 5.
Clinical trials with Dr. Yu by phase
- 1Phase 1: 1 trial
- 1Phase 1/2: 1 trial
- NonePhase 2: no trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Yu's trials
- Pancreatic Neoplasms
- Pancreatic Diseases
- Carcinoma, Adenoid Cystic
- Pancreatic Cyst
- Thromboembolism
Investigators on the most trials with Dr. Yu
- Richy Agajanian, MD1 shared trial
- Edward R. Arrowsmith, MD1 shared trial
- Rama Balaraman, MD1 shared trial
Recent clinical trials with Dr. Yu
Safety, Pharmacokinetics (PK), and Efficacy of ONC-392 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumors and NSCLC: An Open Label Phase IA/IB Study. Preserve CTLA4 Checkpoint Function (PRESERVE-001) (opens in a new tab)
Predicting Effective Therapy in Pancreatic Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Kenneth Ho-Ming Yu received $86,317 in industry payments from 2016 to 2025
CMS Open Payments shows 113 general payments to Dr. Yu from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 76% of the total. Ipsen Biopharmaceuticals, Inc paid the most, $46,320.
General payments to Dr. Yu by program year, 2016 to 2025
General payments to Dr. Yu by kind, 2016 to 2025
- Consulting fees$65,98476%
- Travel and lodging$13,90816%
- Food and beverage$3,4094%
- Speaker and faculty fees$2,9003%
- Education$1170%
Companies that paid Dr. Yu the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Kenneth Ho-Ming Yu graduated from The Johns Hopkins University School of Medicine
Dr. Yu graduated from The Johns Hopkins University School of Medicine in 1999.
- Medical school
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Kenneth Ho-Ming Yu accepts plans from 13 insurance carriers
Dr. Yu is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.
- Aetna
- Excellus BlueCross BlueShield
- Blue Cross Blue Shield of Michigan
- United Healthcare
- Blue Cross Blue Shield of Massachusetts
- HCSC
- MVP Health Care
- Regence Health Plans
- +5 more carriersWith a free account
Plan types Dr. Yu accepts, by number of carriers
- Medicare8
- PPO8
- POS5
- EPO4
- HMO4
- Medicaid1
Source: Dmand AI Insurance Network Data
Sources for Dr. Kenneth Ho-Ming Yu's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Kenneth Ho-Ming Yu
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Kenneth Ho-Ming Yu's NPI number?
Dr. Kenneth Ho-Ming Yu's NPI number is 1073554440. It was assigned on June 9, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Kenneth Ho-Ming Yu?
Dr. Kenneth Ho-Ming Yu is a medical oncologist in New York, New York. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Kenneth Ho-Ming Yu practice?
Dr. Yu practices at 1275 York Avenue, New York, NY 10065. Dr. Yu's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Yu to 3 group practices and clinics and 2 medical groups.
What is Dr. Kenneth Ho-Ming Yu's medical license number?
Dr. Yu's New York license number on file is 257085, one of the licenses on file in 3 states.
Which states has Dr. Kenneth Ho-Ming Yu been licensed in?
Dmand AI has state licenses on file for Dr. Yu in New York (2010 to 2025), New Jersey (2019 to 2027) and Pennsylvania (2000 to 2010).
Which hospitals is Dr. Kenneth Ho-Ming Yu affiliated with?
Dr. Yu practices at Memorial Sloan Kettering Cancer Center in New York, New York.
What medical group is Dr. Kenneth Ho-Ming Yu part of?
Dr. Yu is linked to Memorial Sloan Kettering Cancer Center. Dmand AI links Dr. Yu to 2 more medical groups.
Does Dr. Kenneth Ho-Ming Yu accept Medicare?
Yes. CMS data shows Dr. Yu billed Medicare for 786 services in 2024, and Dr. Yu accepts Medicare assignment.
Does Dr. Kenneth Ho-Ming Yu offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Yu as offering telehealth services.
What is Dr. Kenneth Ho-Ming Yu's MIPS score?
Dr. Yu's MIPS final score for performance year 2024 is 80 out of 100, reported as part of a group.
Show 10 more questionsShow fewer questions
How many Medicare patients does Dr. Kenneth Ho-Ming Yu see?
CMS counts 167 Medicare patients who saw Dr. Yu in 2024, with an average age of 75.
Is Dr. Kenneth Ho-Ming Yu board certified?
Yes. Dr. Yu is board certified in medical oncology by the American Board of Internal Medicine.
What services does Dr. Kenneth Ho-Ming Yu bill to Medicare?
In 2024, Dr. Yu's most billed Medicare services were office visit, established patient (99214), hospital inpatient care (99233) and office visit, new patient (99205).
Where did Dr. Kenneth Ho-Ming Yu go to medical school?
Dr. Yu graduated from The Johns Hopkins University School of Medicine in 1999.
What drugs does Dr. Kenneth Ho-Ming Yu prescribe most?
In 2024 Medicare Part D data, Dr. Yu's most prescribed drugs by claims were Pantoprazole Sodium, Zenpep and Creon.
Has Dr. Kenneth Ho-Ming Yu received payments from drug or device companies?
CMS Open Payments shows $86,317 in general payments to Dr. Yu from 13 companies from 2016 to 2025. The largest total came from Ipsen Biopharmaceuticals, Inc.
How long has Dr. Kenneth Ho-Ming Yu been practicing?
Dr. Yu graduated from medical school in 1999, 27 years ago.
Does Dr. Kenneth Ho-Ming Yu do research?
Dmand AI links 94 publications to Dr. Yu, published from 2011 to 2025. Dr. Yu has worked on 7 clinical trials.
Who does Dr. Kenneth Ho-Ming Yu publish with?
Dr. Yu's most frequent co-authors are David P. Kelsen, MD (27 shared papers), Eileen M. O'Reilly, MD (27 shared papers) and Anna M. Varghese, MD (24 shared papers).
What insurance does Dr. Kenneth Ho-Ming Yu accept?
Dr. Yu is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.
Selling to medical oncology practices?
See medical oncologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card